Echocardiographic hemodynamics correlate with differences in DOAC-specific bleeding and stroke rates in non-valvular

Michael P O'Shea1,2,3, Ali Yusuf4, Eiad Habib4

  • 1Mayo Clinic, 134000 E Shea Blvd, Scottsdale, AZ, 85259, USA. osheam12@tcd.ie.

PubMed

Insights

Direct oral anticoagulants (DOACs) reduce stroke risk in non-valvular atrial fibrillation. Elevated right ventricular systolic pressure (RVSP) increases bleeding risk with dabigatran and rivaroxaban, but not apixaban.

Area of Science:

  • Cardiology
  • Pharmacology
  • Medical Imaging

Background:

  • Direct oral anticoagulants (DOACs) are standard for stroke prevention in non-valvular atrial fibrillation/flutter (NVAF).
  • Different DOACs exhibit varying bleeding profiles, with apixaban noted for the lowest risk.
  • Right ventricular systolic pressure (RVSP) is an echocardiographic measure that may influence bleeding risk.

Purpose of the Study:

  • To investigate the interaction between DOAC selection and RVSP on echocardiogram concerning bleeding rates.
  • To test the hypothesis that elevated RVSP is linked to increased bleeding, potentially modulated by DOAC pharmacologic properties.

Main Methods:

  • Retrospective analysis of a clinical database involving patients who underwent echocardiography.
  • Multivariable regression models were employed to assess bleeding rates, adjusting for confounders.
  • Interaction terms for DOAC choice and RVSP status were incorporated into the models.

Main Results:

  • Apixaban was associated with lower bleeding rates compared to rivaroxaban and dabigatran overall.
  • No significant difference in bleeding rates was observed between DOACs in patients without elevated RVSP.
  • In patients with RVSP ≥45mmHg, dabigatran and rivaroxaban showed significantly increased bleeding rates (90% and 86% increase, respectively) compared to apixaban.

Conclusions:

  • Elevated RVSP is a significant risk factor for excess bleeding in patients on certain DOACs.
  • The increased bleeding risk associated with elevated RVSP was observed with dabigatran and rivaroxaban, but not apixaban.
  • These findings highlight the importance of considering RVSP in conjunction with DOAC choice for personalized bleeding risk assessment in NVAF patients.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
621
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
3.1K
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
397
Assessing Blood pressure using a doppler ultrasound01:19

Assessing Blood pressure using a doppler ultrasound

To obtain accurate blood pressure measurements in clinical settings, especially when traditional methods are insufficient, healthcare professionals utilize the Doppler ultrasound technique. This method uses high-frequency sound waves to detect blood flow within the arteries, which is crucial for patients with conditions that complicate circulatory system assessment.
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
2.3K
Correlation between ECG and Cardiac Cycle01:25

Correlation between ECG and Cardiac Cycle

The electrical signals recorded on an electrocardiogram (ECG) occur before the mechanical processes of contraction and relaxation during the cardiac cycle.
A cardiac action potential originates in the SA node and spreads throughout the atria and the AV node in approximately 0.03 seconds. This results in the P wave in an ECG and triggers atrial contraction. The action potential is then briefly slowed at the AV node, allowing the atria to contract and fill the ventricles with blood before...
11.7K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
473